Literature DB >> 19398011

The L1 retrotransposition assay: a retrospective and toolkit.

Sanjida H Rangwala1, Haig H Kazazian.   

Abstract

LINE1s (L1s) are a class of mammalian non-LTR (long terminal repeat) retroelements that make up nearly 20% of the human genome. Because of the difficulty of studying the mobilization of endogenous L1s, an exogenous cell culture retrotransposition assay has become integral to research in L1 biology. This assay has allowed for investigation of the mechanism and consequences of mobilization of this retroelement, both in cell lines and in whole animal models. In this paper, we outline the genesis of in vitro retrotransposition systems which led to the development of the L1 retrotransposition assay in the mid-1990s. We then provide a retrospective, describing the many uses and variations of this assay, ending with caveats and predictions for future developments. Finally, we provide detailed protocols on the application of the retrotransposition assay, including lists of constructs available in the L1 research community and cell lines in which this assay has been applied.

Entities:  

Mesh:

Year:  2009        PMID: 19398011      PMCID: PMC2763987          DOI: 10.1016/j.ymeth.2009.04.012

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  103 in total

1.  Genomic deletions created upon LINE-1 retrotransposition.

Authors:  Nicolas Gilbert; Sheila Lutz-Prigge; John V Moran
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

2.  Identification of critical CpG sites for repression of L1 transcription by DNA methylation.

Authors:  K Hata; Y Sakaki
Journal:  Gene       Date:  1997-04-21       Impact factor: 3.688

3.  Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition.

Authors:  Q Feng; J V Moran; H H Kazazian; J D Boeke
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

4.  Human L1 retrotransposition: cis preference versus trans complementation.

Authors:  W Wei; N Gilbert; S L Ooi; J F Lawler; E M Ostertag; H H Kazazian; J D Boeke; J V Moran
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Human LINE retrotransposons generate processed pseudogenes.

Authors:  C Esnault; J Maestre; T Heidmann
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

6.  Rapid amplification of a retrotransposon subfamily is evolving the mouse genome.

Authors:  R J DeBerardinis; J L Goodier; E M Ostertag; H H Kazazian
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

7.  LINE-mediated retrotransposition of marked Alu sequences.

Authors:  Marie Dewannieux; Cécile Esnault; Thierry Heidmann
Journal:  Nat Genet       Date:  2003-08-03       Impact factor: 38.330

8.  LINE-1 ORF1 protein enhances Alu SINE retrotransposition.

Authors:  Nicholas Wallace; Bradley J Wagstaff; Prescott L Deininger; Astrid M Roy-Engel
Journal:  Gene       Date:  2008-04-24       Impact factor: 3.688

9.  Trex1 prevents cell-intrinsic initiation of autoimmunity.

Authors:  Daniel B Stetson; Joan S Ko; Thierry Heidmann; Ruslan Medzhitov
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

10.  mRNA retroposition in human cells: processed pseudogene formation.

Authors:  J Maestre; T Tchénio; O Dhellin; T Heidmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  20 in total

1.  Retrotransposition of marked SVA elements by human L1s in cultured cells.

Authors:  Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2011-06-02       Impact factor: 6.150

2.  sRNA/L1 retrotransposition: using siRNAs and miRNAs to expand the applications of the cell culture-based LINE-1 retrotransposition assay.

Authors:  Pablo Tristan-Ramos; Santiago Morell; Laura Sanchez; Belen Toledo; Jose L Garcia-Perez; Sara R Heras
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-02-10       Impact factor: 6.237

3.  Type I interferon controls propagation of long interspersed element-1.

Authors:  Qiujing Yu; Christopher J Carbone; Yuliya V Katlinskaya; Hui Zheng; Ke Zheng; Mengcheng Luo; P Jeremy Wang; Roger A Greenberg; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2015-02-25       Impact factor: 5.157

4.  An S/MAR-based L1 retrotransposition cassette mediates sustained levels of insertional mutagenesis without suffering from epigenetic silencing of DNA methylation.

Authors:  Danny Rangasamy
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

5.  Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution.

Authors:  Kimberly Schmitt; Kejun Guo; Malinda Algaier; Autumn Ruiz; Fang Cheng; Jianming Qiu; Silke Wissing; Mario L Santiago; Edward B Stephens
Journal:  Virology       Date:  2011-08-25       Impact factor: 3.616

6.  LINE-1 Cultured Cell Retrotransposition Assay.

Authors:  Huira C Kopera; Peter A Larson; John B Moldovan; Sandra R Richardson; Ying Liu; John V Moran
Journal:  Methods Mol Biol       Date:  2016

7.  LINE-1 retrotransposition events affect endothelial proliferation and migration.

Authors:  Ferya Banaz-Yaşar; Gyde Steffen; Jessica Hauschild; Birthe M Bongartz; Gerald G Schumann; Süleyman Ergün
Journal:  Histochem Cell Biol       Date:  2010-11-11       Impact factor: 4.304

Review 8.  Response of transposable elements to environmental stressors.

Authors:  Isabelle R Miousse; Marie-Cecile G Chalbot; Annie Lumen; Alesia Ferguson; Ilias G Kavouras; Igor Koturbash
Journal:  Mutat Res Rev Mutat Res       Date:  2015-05-30       Impact factor: 5.657

9.  Characterization of LINE-1 ribonucleoprotein particles.

Authors:  Aurélien J Doucet; Amy E Hulme; Elodie Sahinovic; Deanna A Kulpa; John B Moldovan; Huira C Kopera; Jyoti N Athanikar; Manel Hasnaoui; Alain Bucheton; John V Moran; Nicolas Gilbert
Journal:  PLoS Genet       Date:  2010-10-07       Impact factor: 5.917

Review 10.  Human transposon tectonics.

Authors:  Kathleen H Burns; Jef D Boeke
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.